
Cizumab 400 Solution for Infusion
Marketer
Hetero Drugs Ltd
Salt Composition
Bevacizumab (400mg)
Overview Cizumab 400 Solution for Infusion
Cizumab 400mg Infusion Solution is a cancer treatment agent. Its application spans various cancers, including colorectal, non-small cell lung, renal cell, brain, ovarian, and cervical cancers. Its mechanism involves angiogenesis inhibition, hindering tumor growth by restricting blood supply. Highly effective, it's often a first-line therapy in combination with other chemotherapeutic agents, administered intravenously via infusion or a subcutaneous port. Dosage and treatment duration are tailored by your physician, who will also monitor for infusion reactions like hypertension and respiratory distress. Treatment continues as long as the disease remains controlled and side effects are tolerable, with discontinuation determined by your doctor. Regular monitoring of blood pressure and urinary protein levels may be recommended. Common side effects include rectal hemorrhage, altered taste perception, and cephalalgia. Pre-surgical notification is vital due to its potential to impair wound healing. Increased bleeding risk necessitates prompt medical attention for any unusual bleeding episodes. Disclose pregnancy, pregnancy plans, or breastfeeding to your physician. Comprehensive medication disclosure to your healthcare provider is crucial due to potential drug interactions.
Uses of Cizumab 400 Solution for Infusion
Colorectal cancer, ovarian neoplasm, cervical carcinoma, renal cell carcinoma, brain cancer, and non-small cell lung carcinoma.
Major Benefits of Cizumab 400 Solution for Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cizumab 400 Solution for Infusion:
- Exfoliative dermatitis
- High blood pressure
- Nosebleeds
- Protein in urine
- Decreased appetite
- Electrolyte imbalance
- Peripheral sensory neuropathy
- Breathlessness
- Thromboembolism
- Wound healing complications
- Ovarian failure
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Mucosal inflammation
- Abscess
- Cellulitis
- Hypersensitivity
- Rectovaginal fistula
How to use Cizumab 400 Solution for Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cizumab 400 Solution for Infusion works:
Cizumab 400 Infusion Solution is an anti-angiogenesis agent. Its mechanism of action involves the inhibition of vascular endothelial growth factor (VEGF), thereby preventing the development of new blood vessels supplying tumors with essential oxygen and nutrients.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cizumab 400 Solution for Infusion may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Cizumab 400 Solution for Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Cizumab 400 Solution for Infusion while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Cizumab 400 Infusion Solution can induce adverse reactions that might compromise driving capabilities. Reported side effects include drowsiness and loss of consciousness, potentially affecting safe operation of a vehicle.
KidneySAFE IF PRESCRIBED
The use of Cizumab 400 Solution for Infusion in individuals with renal impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary for this patient population. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The intravenous Cizumab 400 solution appears to pose minimal risk for individuals with hepatic impairment. Preliminary findings indicate dosage modification may be unnecessary in this population. Physician consultation is advised.
What if you forget to take Cizumab 400 Solution for Infusion :
Should you forget a scheduled Cizumab 400 Infusion Solution dose, contact your physician for guidance.
Facts to Know About Cizumab 400 Solution for Infusion
| Label | Value |
|---|---|
| Chemical Classification | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | VEGF inhibitor |
